Tristan Gonzalez is a renowned health economist with a vast experience in the pharmaceutical industry. With various managerial roles at AstraZeneca and Alexion Pharmaceuticals, he is an expert in market access and innovative value strategies in neurology and oncology. He has also held positions as a Health Economics Manager at Amgen and a consultant at Deloitte in health economics and market access strategy. Tristan has an educational background in both pharmacy and health economics from the University of Reading and the University of York, respectively. He has also worked as a pharmacist in various capacities, including a pre-registration pharmacist at AstraZeneca and the National Health Service.